Extranodal Natural Killer/T Cell Lymphoma
5 clinical trials · Condition
◉ Watch Extranodal Natural Killer/T Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Tislelizumab Combined with Mitoxantrone Hydrochloride Liposome in Extranodal Natural Killer/T Cell Lymphoma (NCT05464433) | Sun Yat-sen University | 2022-06-23 |
| A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma (NCT05343377) | The First Affiliated Hospital with Nanjing Medical University | 2022-06-01 |
| A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL) (NCT03595657) | CStone Pharmaceuticals | 2018-06-12 |
Track Extranodal Natural Killer/T Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.